A new trend among large pharmaceutical companies is the acquisition of drugs at earlier stages than ever before. The change may be due in part to the expiration of patents on current big sellers, as ... 
09 Aug 2010
Business News
As this article on the Alzheimer Research Forum shows, nonprofit organizations are not immune to patent infringement lawsuits. In the case highlighted here, Jackson Lab is named as one of several ... 
01 Jul 2010
Business News
Responses: 2
MJFF is pleased to announce an agreement with Weill Cornell Medical College allowing MJFF-funded investigators performing research on LRRK2 to obtain a no-cost license for use of Dr. Chenjian ... 
11 Jun 2010
WASHINGTON (Reuters/By Lisa Richwine) - Major drugmakers will share data from their clinical trials for Alzheimer's and Parkinson's disease in an effort to speed the development of new medicines ... 
11 Jun 2010
Clinical Trial News
May 19, 2010/Burlingame, CA/ GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine ... 
31 May 2010
Business News
Responses: 1
Feb 16, 2010 (Close-Up Media via COMTEX) --  ... 
16 Feb 2010
Business News
ZURICH, Dec 2 (Reuters) - Swiss biotech Addex Pharmaceuticals (ADXN.S) extended a research deal with U.S. drugmaker Merck & Co (MRK.N) by a year, seeking to develop a treatment for Parkinson's ... 
02 Dec 2009
Business News
The Scientist published their list of the top 10 innovations in the life sciences from 2009. Check out these tools that will propel scientific innovation and progress to come! ... 
01 Dec 2009
WASHINGTON — US pharmaceutical giant Merck & Co. finalized its acquisition of rival Schering-Plough on Tuesday, a 41-billion-dollar deal creating the number two firm in the sector. ... 
04 Nov 2009
Business News
We've launched a brand new section on The Business of Science, where you'll be able to find information on the business aspects of developing new therapies for Parkinson's disease. We're kicking off ... 
02 Nov 2009
PDOR Spotlight, Q&A